EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes


Journal of Dermatology 22(1): 4-9
The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes
The correlation between the susceptibilities of Propionibacterium acnes strains to two Kampo formulations and these to their ingredients (Kampo crude drugs) was examined. Two out of 19 Kampo crude drugs, Coptidis Rhizoma (CR) and Phellodendri Cortex (PC), inhibited the growth of P. acnes significantly. The patterns of distribution of the minimal inhibitory concentrations of Keigai-rengyo-to (KRT) and of Seijo-bofu-to (SBT) were almost the same as those of the Kampo crude drugs, except CR and PC. Furthermore, no correlations between MICs of Kampo formulations and those of their ingredients against P. acnes were found. This might be due to mutual inhibition or to differences in anti-bacterial mechanisms between the two Kampo formulations and their ingredients. The Kampo formulations, composed of CR, PC and a few other kinds of Kampo crude drugs, might be more susceptible against P. acnes, since higher concentrations of the effective ingredients can be achieved.


Accession: 002980975

PMID: 7897023

DOI: 10.1111/j.1346-8138.1995.tb03332.x



Related references

The correlation of Kampoh formulations and their ingredients on anti-bacterial activities of Propionibacterium acnes. Journal of Investigative Dermatology 101(3): 454, 1993

Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes. Journal of Dermatology 23(5): 310-314, 1996

Activity of eleven kampo formulations and eight kampo crude drugs against Propionibacterium acnes isolated from acne patients: retrospective evaluation in 1990 and 1995. Journal of Dermatology 23(12): 871-875, 1996

Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations. Journal of International Medical Research 25(6): 318-324, 1998

Anti bacterial effect of kampoh formulations and kampoh drugs on propionibacterium acnes. Acta Dermatologica (Kyoto) 85(4): 515- 520, 1990

Evaluation of anti-microbial activities of ZnO, citric acid and a mixture of both against Propionibacterium acnes. International Journal of Cosmetic Science 38(6): 550-557, 2016

Corynebacterium parvum propionibacterium acnes and its adjuvant and anti tumor activities in c 3h mice of different ages. International Journal of Immunopharmacology 4(4): 282, 1982

Inactivation of splenomegaly inducing and anti tumor activities of propionibacterium acnes by bacteriolytic enzymes. Abstracts of the Annual Meeting of the American Society for Microbiology 83: K104, 1983

Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. International Journal of Systematic and Evolutionary Microbiology 65(12): 4776-4787, 2016

T-cell-mitogenicity of Propionibacterium acnes Differences between fresh clinical bacterial isolates and the laboratory strain P acnes P37. Archives of Dermatological Research 293(1-2): 92, February, 2001